Stockscreener 앱 받기
0.5825
11.34%
-0.0745
시간 외 거래:
.56
-0.0225
-3.86%
Decoy Therapeutics Inc 주식(DCOY)의 최신 뉴스
Decoy Therapeutics Announces 1-for-12 Reverse Stock Split - Finviz
Decoy Therapeutics Announces Reverse Stock Split to Maintain Listing - TipRanks
Decoy Therapeutics to implement 1-for-12 reverse stock split - Investing.com India
Biotech Decoy Therapeutics shrinks shares 12-to-1 to meet Nasdaq $1 rule - Stock Titan
SLRX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Decoy Therapeutics (DCOY) Stock Analysis Report | Financials & Insights - Benzinga España
Decoy Therapeutics shareholders approve reverse stock split and equity plan - Investing.com Nigeria
Decoy Therapeutics shareholders approve reverse stock split and equity plan By Investing.com - Investing.com India
Decoy Therapeutics Shareholders Approve Plan and Reverse Split - TipRanks
DCOY Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
DCOY Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Decoy Therapeutics Joins Webull Corporate Connect Service Platfo - GuruFocus
Decoy Therapeutics Joins Webull Corporate Connect Service Platform - marketscreener.com
Follow Decoy Therapeutics updates on Webull app now - Stock Titan
Decoy Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial - Finviz
Decoy Therapeutics Participates in Virtual Investor "What This Means" Segment Highlighting Recently Announced Global Access Commitment Agreement - Finviz
Gates Foundation backs Decoy's push for rapid, low-cost antivirals - Stock Titan
Decoy Therapeutics (DCOY) Stock Price, News & Analysis - MarketBeat
This MasTec Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
Decoy Therapeutics (DCOY) Receives "Buy" Rating from Ladenburg T - GuruFocus
Hanish, director at Salarius, sells shares worth $17 By Investing.com - Investing.com Nigeria
DCOY Stock Price, News & Analysis - Stock Titan
Decoy Therapeutics Inc Share Price USD0.0001 - Hargreaves Lansdown
DCOY Stock Price and Chart — NASDAQ:DCOY - TradingView — Track All Markets
Decoy Therapeutics Inc. (DCOY) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of A Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform - marketscreener.com
Decoy Therapeutics Reaches Global Access Commitment Agreement With Gates Foundation; Stock Up - Nasdaq
Decoy Therapeutics Faces Challenges Amid Market Fluctuations - StocksToTrade
Decoy Therapeutics Faces Major Headwinds Amid Financial Struggles - timothysykes.com
DCOYDECOY THERAPEUTICS INC Latest Stock News & Market Updates - Stock Titan
Decoy Therapeutics reaches global access commitment agreement to focus on development of a globally accessible, scalable peptide-conjugate manufacturing platform - marketscreener.com
Decoy Therapeutics rises as Gates Foundation backs antiviral drug access - TradingView
Decoy Therapeutics Reaches Global Access Commitment Agreement To Focus On Development Of A Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform - TradingView — Track All Markets
Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of a Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform - PR Newswire
Salarius Pharmaceuticals shareholders re-elect directors and approve proposals at annual meeting - Investing.com Nigeria
What is the current Price Target and Forecast for Decoy Therapeutics Inc (DCOY) - Zacks Investment Research
Salarius announces planned corporate name change to Decoy Therapeutics - MSN
symbol__ Stock Quote Price and Forecast - CNN
Salarius Pharmaceuticals Rebrands as Decoy Therapeutics on Nasdaq - The Globe and Mail
Salarius Pharmaceuticals changes name to Decoy Therapeutics - marketscreener.com
Salarius Pharmaceuticals to rebrand as Decoy Therapeutics, change ticker By Investing.com - Investing.com Australia
Salarius Pharmaceuticals stock soars on name change to Decoy Therapeutics By Investing.com - Investing.com South Africa
Salarius Pharmaceuticals to rebrand as Decoy Therapeutics, change ticker - Investing.com
Salarius Pharmaceuticals stock soars on name change to Decoy Therapeutics - Investing.com
Salarius Pharmaceuticals, Inc. Announces Rebranding to Decoy Therapeutics Inc. with Nasdaq Trading Under DCOY Starting January 8, 2026 - Quiver Quantitative
Salarius Pharmaceuticals Changes Corporate Name to Decoy - GlobeNewswire
3.69%
0.68%
자본화:
|
볼륨(24시간):